NVZMY (Novonesis (Novozymes) B) Capex-to-Operating-Income : 0.20 (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Novonesis (Novozymes) B's Capital Expenditure for the three months ended in Mar. 2025 was $-59.68 Mil. Its Operating Income for the three months ended in Mar. 2025 was $298.05 Mil.

Hence, Novonesis (Novozymes) B's Capex-to-Operating-Income for the three months ended in Mar. 2025 was 0.20.

Novonesis (Novozymes) B Capex-to-Operating-Income Historical Data

The historical data trend for Novonesis (Novozymes) B's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Capex-to-Operating-Income Chart

Novonesis (Novozymes) B Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Capex-to-Operating-Income

Get a 7-Day Free Trial

0.26

0.32

0.65

0.45

0.55

Novonesis (Novozymes) B Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25
Capex-to-Operating-Income	Get a 7-Day Free Trial															0.46	0.44	0.89	0.49	0.20

Competitive Comparison of Novonesis (Novozymes) B's Capex-to-Operating-Income

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novonesis (Novozymes) B's Capex-to-Operating-Income Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Capex-to-Operating-Income falls into.

Save Embed

;

Save Embed

;

Novonesis (Novozymes) B Capex-to-Operating-Income Calculation

Novonesis (Novozymes) B's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-376.754)	/	690.052
	=	0.55

Novonesis (Novozymes) B's Capex-to-Operating-Income for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (-59.676)	/	298.054
	=	0.20

Novonesis (Novozymes) B (OTCPK:NVZMY) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Novonesis (Novozymes) B Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » Capex-to-Operating-Income

Comparable Companies

Traded in Other Exchanges

NVZMF:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM:Germany NZYM:Austria

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.